Sayed Shah, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2206 E 52nd St, Ste A, Davenport, IA 52807 Phone: 563-355-7411 Fax: 563-355-7431 |
Bharat A Motwani, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1228 E Rusholme St Ste 3060, Davenport, IA 52803 Phone: 563-421-4244 Fax: 563-421-4249 |
Dr. Allan Hu, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1227 E Rusholme St, Davenport, IA 52803 Phone: 563-421-1000 |
News Archive
Researchers at Columbia University in New York have conducted a study showing that patients with coronavirus disease 2019 (COVID-19) who require intubation and mechanical ventilation due to respiratory distress may benefit from treatment with the hormone melatonin.
Javelin Pharmaceuticals, Inc., a leading developer and marketer of specialty pharmaceutical products for pain management, today announced that its New Drug Application (NDA) submitted on December 2, 2009 to the US Food and Drug Administration (FDA) for its investigational product candidate, Dylojectâ„¢ (diclofenac sodium) Injection, has received an FDA PDUFA date of October 3, 2010. This NDA review is in support of US marketing approval and registration of Dyloject for the management of acute moderate-to-severe pain in adults.
Escherichia coli K1 (E. coli K1) continues to be a major threat to the health of young infants. Affecting the central nervous system, it causes neonatal meningitis by multiplying in immune cells, such as macrophages, and then disseminating into the bloodstream to subsequently invade the blood-brain barrier.
PCI Biotech (PCIB) the Norwegian biopharmaceutical company, reported today that it has chosen bileduct cancer as the next indication for the use of its PCI (photochemical internalisation) localised cancer therapy. In this indication PCI Biotech's proprietary photosensitiser Amphinex® will be used in combination with the generic cytotoxic agent gemcitabine. The aim is to start the clinical Proof of Concept study within end of 1H 2013.
Just in time for peak head lice season, ParaPRO, LLC has launched MyHeadLiceTreatment.com, a free, engaging and comprehensive "one-stop shop" about head lice. Treating head lice can be an issue. The U.S. Centers for Disease Control and Prevention estimate between 6 to 12 million cases of head lice infestations will occur this year - most in children 3 to 12 years old.
› Verified 1 days ago